Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Pernix Therapeutics Holdings Inc.
Fiscal year is January-December. All values USD millions. 2010 2011 2012 2013 5-year trend
Sales/Revenue - 33.23M 60.61M 61.31M 84.87M
Cost of Goods Sold (COGS) incl. D&A - 7.74M 18.41M 26.58M 52.55M
COGS excluding D&A - 6.5M 16.11M 23.38M 43.87M
Depreciation & Amortization Expense - 1.24M 2.3M 3.2M 8.68M
Depreciation - 61,322 97,498 323,644 1.34M
Amortization of Intangibles - 1.18M 2.21M 2.88M 7.33M
Gross Income - 25.49M 42.2M 34.73M 32.33M
2010 2011 2012 2013 5-year trend
SG&A Expense - 15.87M 23.08M 35.58M 57.36M
Research & Development - 998,224 922,432 731,665 4.8M
Other SG&A - 14.87M 22.16M 34.85M 52.56M
Other Operating Expense - 0 384,943 0 0
Unusual Expense - - 4.81M 600,474 20.71M
EBIT after Unusual Expense - - (4.81M) (600,474) (20.71M)
Non Operating Income/Expense - 1.17M 0 0 3.4M
Non-Operating Interest Income - 33,624 40,622 74,000 134,000
Equity in Affiliates (Pretax) - - 0 (240,195) 0
Interest Expense - 28,000 212,000 168,823 4.18M
Gross Interest Expense - 28,000 212,000 168,823 4.18M
Interest Capitalized - - 0 0 0
Pretax Income - 10.79M 13.75M (1.78M) (46.39M)
Income Tax - 1.49M 4.59M (373,999) (20.76M)
Income Tax - Current Domestic - 4.54M 7.54M 1.46M 1.76M
Income Tax - Current Foreign - 0 0 - -
Income Tax - Deferred Domestic - (3.06M) (2.95M) (1.84M) (22.52M)
Income Tax - Deferred Foreign - 0 0 - -
Income Tax Credits - 0 0 0 0
Equity in Affiliates - 0 (814,351) 0 0
Other After Tax Income (Expense) - 0 - 0 0
Consolidated Net Income - 9.31M 8.35M (1.41M) (25.64M)
Minority Interest Expense - 0 0 0 0
Net Income - 9.31M 8.35M (1.41M) (25.64M)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries - 9.31M 8.35M (1.41M) (25.64M)
Preferred Dividends - 0 0 0 0
Net Income Available to Common - 9.31M 8.35M (1.41M) (25.64M)
EPS (Basic) - 0.40 0.35 (0.05) (0.70)
Basic Shares Outstanding - 23.42M 23.99M 28.15M 36.44M
EPS (Diluted) - 0.40 0.34 (0.05) (0.70)
Diluted Shares Outstanding - 23.42M 24.46M 28.15M 36.44M
EBITDA - 10.86M 21.03M 2.35M (16.36M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.